Oragenics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on August 20, 2010. The report details a corporate governance action taken by the Board of Directors on the same date regarding the company's Bylaws.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is not a financial statement and contains no quantitative financial data.
Material Changes
The Board of Directors adopted an amendment to Section 1 of Article IV of the Company's Bylaws effective immediately. This amendment permits the issuance of uncertificated shares, making the Company's stock eligible for the Direct Registration System (DRS). The DRS allows for the electronic transfer of shares and maintenance of securities on the issuer's or transfer agent's books without physical stock certificates.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The report is strictly limited to the description of the Bylaw amendment.
Key Facts for Investor Verification
- The amendment to the Bylaws was adopted on August 20, 2010, and is effective immediately.
- The change enables the use of the Direct Registration System (DRS) for uncertificated shares.
- The full text of the amendment is attached as Exhibit 3.1 to the filing.
- The report was signed by David B. Hirsch, President and Chief Executive Officer, on August 24, 2010.